Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
biotech
boston blog main
clinical trials
life sciences
national blog main
rna interference
3
×
alirocumab
amgen
boston top stories
deals
evolocumab
fda
inclisiran
national top stories
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
alexion pharmaceuticals
boehringer ingelheim
boston
dicerna pharamceuticals
drugs
evercore isi
heart attack
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
joseph swartz
medicines co.
novartis
patisiran
pcsk9
roche
sanofi
stroke
svb leerink
the medicines company
What
drug
3
×
medicines
3
×
cholesterol
medco
new
pharmaceuticals
acquire
agreed
alnylam
based
billion
brings
cash
caught
causing
company
compound
data
deal
dicerna
disease
evidence
eye
fda
gene
heart
hepatitis
intended
lasting
long
looms
lowering
novartis
partner
pay
pharma
poised
presented
producing
protein
Language
unset
Current search:
medicines
×
drug
×
" rna interference "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
